Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lah

Showing results (791-800 of 1,064) with videos related to

Pageof 107
Sort By:
Plos One|December 5, 2024
Ethical attitudes and perspectives of AI use in medicine between Croatian and Slovenian faculty members of school of medicine: Cross-sectional studyŠtefan Grosek, Stjepan Štivić, Ana Borovečki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 18, 2025
Safety and efficacy of pegtibatinase enzyme replacement therapy in adults with classical homocystinuria in the COMPOSE® phase 1/2 randomized trialCan Ficicioglu, Janet A Thomas, Jaya Ganesh, et al.
Oncotarget|November 18, 2015
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cellsNeža Podergajs, Helena Motaln, Uroš Rajčević, et al.
Molecular Neurodegeneration|October 6, 2018
Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseErik C B Johnson, Eric B Dammer, Duc M Duong, et al.
Journal for Immunotherapy of Cancer|April 5, 2023
Engineering second-generation TCR-T cells by site-specific integration of TRAF-binding motifs into the <i>CD247</i> locusSangjoon Lah, Segi Kim, In Kang, et al.
Annals of Clinical and Translational Neurology|March 10, 2015
CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?William T Hu, Kelly D Watts, Leslie M Shaw, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 12, 2025
CSF proteomics reveals changes in myelin and synaptic biology after Spectris treatmentMihály Hajós, Kiran Pandey, Annabelle C Singer, et al.
Molecular Genetics and Metabolism Reports|September 30, 2022
Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing dataMelissa Lah, Keziah Cook, Dumingu Aparna Gomes, et al.
Clinical Proteomics|June 10, 2020
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's diseaseMaotian Zhou, Rafi U Haque, Eric B Dammer, et al.
Frontiers in Molecular Neuroscience|January 9, 2019
Effects of <i>APOE</i> Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's DiseaseJingting Dai, Erik C B Johnson, Eric B Dammer, et al.
Pageof 107

Showing results (791-800 of 1,064) with videos related to

Sort By:
Pageof 107
Plos One|December 5, 2024
Ethical attitudes and perspectives of AI use in medicine between Croatian and Slovenian faculty members of school of medicine: Cross-sectional studyŠtefan Grosek, Stjepan Štivić, Ana Borovečki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 18, 2025
Safety and efficacy of pegtibatinase enzyme replacement therapy in adults with classical homocystinuria in the COMPOSE® phase 1/2 randomized trialCan Ficicioglu, Janet A Thomas, Jaya Ganesh, et al.
Oncotarget|November 18, 2015
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cellsNeža Podergajs, Helena Motaln, Uroš Rajčević, et al.
Molecular Neurodegeneration|October 6, 2018
Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseErik C B Johnson, Eric B Dammer, Duc M Duong, et al.
Journal for Immunotherapy of Cancer|April 5, 2023
Engineering second-generation TCR-T cells by site-specific integration of TRAF-binding motifs into the <i>CD247</i> locusSangjoon Lah, Segi Kim, In Kang, et al.
Annals of Clinical and Translational Neurology|March 10, 2015
CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?William T Hu, Kelly D Watts, Leslie M Shaw, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 12, 2025
CSF proteomics reveals changes in myelin and synaptic biology after Spectris treatmentMihály Hajós, Kiran Pandey, Annabelle C Singer, et al.
Molecular Genetics and Metabolism Reports|September 30, 2022
Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing dataMelissa Lah, Keziah Cook, Dumingu Aparna Gomes, et al.
Clinical Proteomics|June 10, 2020
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's diseaseMaotian Zhou, Rafi U Haque, Eric B Dammer, et al.
Frontiers in Molecular Neuroscience|January 9, 2019
Effects of <i>APOE</i> Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's DiseaseJingting Dai, Erik C B Johnson, Eric B Dammer, et al.
Pageof 107